- Home
- SLQT vs GHRS Comparison
SLQT vs GHRS Comparison
Compare SLQT & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- GHRS
- Stock Information
- Founded
- SLQT 1999
- GHRS 2018
- Country
- SLQT United States
- GHRS Ireland
- Employees
- SLQT N/A
- GHRS N/A
- Industry
- SLQT Specialty Insurers
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- GHRS Health Care
- Exchange
- SLQT Nasdaq
- GHRS Nasdaq
- Market Cap
- SLQT 566.4M
- GHRS 583.1M
- IPO Year
- SLQT 2020
- GHRS 2021
- Fundamental
- Price
- SLQT $2.67
- GHRS $10.60
- Analyst Decision
- SLQT Hold
- GHRS Strong Buy
- Analyst Count
- SLQT 1
- GHRS 8
- Target Price
- SLQT $4.00
- GHRS $30.63
- AVG Volume (30 Days)
- SLQT 1.6M
- GHRS 148.1K
- Earning Date
- SLQT 05-12-2025
- GHRS 05-08-2025
- Dividend Yield
- SLQT N/A
- GHRS N/A
- EPS Growth
- SLQT N/A
- GHRS N/A
- EPS
- SLQT N/A
- GHRS N/A
- Revenue
- SLQT $1,456,941,000.00
- GHRS N/A
- Revenue This Year
- SLQT $15.45
- GHRS N/A
- Revenue Next Year
- SLQT $14.68
- GHRS N/A
- P/E Ratio
- SLQT N/A
- GHRS N/A
- Revenue Growth
- SLQT 25.67
- GHRS N/A
- 52 Week Low
- SLQT $1.62
- GHRS $6.00
- 52 Week High
- SLQT $6.86
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- SLQT 38.44
- GHRS 59.36
- Support Level
- SLQT $2.42
- GHRS $9.81
- Resistance Level
- SLQT $2.80
- GHRS $11.50
- Average True Range (ATR)
- SLQT 0.28
- GHRS 0.72
- MACD
- SLQT -0.02
- GHRS 0.23
- Stochastic Oscillator
- SLQT 58.01
- GHRS 89.60
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.